---
title: "PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial"
ocid: "ocds-r6ebe6-0000843130"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000843130"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000843130.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000843130.json"
source: "Public Contracts Scotland"
current_stage: "Tender"
buyer: "University of Glasgow"
published: "2026-09-16"
---

# PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial

Buyer: University of Glasgow  
Current stage: Tender  
OCID: ocds-r6ebe6-0000843130

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000843130)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000843130.json)

## Summary

The University of Glasgow is seeking a supplier to manufacture investigational medicinal products for a clinical trial. The requirement includes final Qualified Person release, storage and distribution to study sites, with an option to provide an integrated interactive response technology system with forecasting capabilities. This is a medicines manufacturing and clinical-trial supply service, classified under CPV 33600000. The work is commissioned by the University of Glasgow and is associated with delivery in Glasgow, with products distributed onward to study sites. The procurement also includes electronic ordering and payment arrangements, and community benefits such as employment and training for priority groups, workforce upskilling, supply-chain development and subcontracting opportunities for SMEs, third-sector organisations and supported businesses. Suppliers must state the community benefits they will deliver.

The buyer invited offers through a selective competitive procedure with negotiation, conducted in two stages and involving successive reduction. Three candidates are to be invited to the second stage, with no further negotiation necessary at that point. The submission deadline set by the buyer is 19 October 2026 at 12:00 UTC, and second-stage invitations are scheduled for 19 October 2026. The initial contract term is 18 months, with an optional extension of up to 12 months; the published lot duration is 900 days. The procurement has one lot. Evaluation includes quality for IMP manufacture, weighted at 18%, and price, weighted at 30%. Variants are not permitted. Electronic submissions in English are required. The financial thresholds include turnover of at least £450,000 a year and specified insurance cover.

This opportunity suits pharmaceutical manufacturers and specialist clinical-trial supply providers able to produce investigational medicinal products under appropriate quality systems and manage Qualified Person release, controlled storage and distribution to multiple study sites. Relevant suppliers should also be capable of providing, or integrating, an interactive response technology system with forecasting functions. The requirement favours organisations with established operational capacity for manufacturing, release, inventory control, logistics and study-site supply over the contract term and any extension. Bidders need at least two years of accounts and annual turnover of £450,000. Required insurance includes product liability of £2 million, public liability of £5 million, employers’ liability of £5 million and professional indemnity of £1 million. Suppliers must also offer credible community-benefit commitments and supply-chain opportunities.

## Notice

PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial, (Including Final Qualified Person Release, Storage and Distribution to Study Sites) and Option to Provide an Integrated IRT System with Forecasting Capabilities. This procurement process is being conducted using the Competitive Procedure with Negotiation (CPN) in accordance with the requirements of Regulation 30 of the PC(S)R 2015. Although this procurement is being conducted under the Competitive Procedure with Negotiation (CPN), it is structured differently from a typical CPN process. This approach has been adopted to enhance the efficiency of evaluating supplier responses across both stages (SPD and ITT). Tender documents available from Public Contracts Scotland. Tender returns should be submitted via Public Contracts Scotland, no paper copies will be accepted. Should paper tenders be submitted, they will be rejected. Further to this any questions or communications regarding individual tender exercises must be sent via the Public Contracts Scotland Portal. Tender queries received through any other channel will not be answered. Should users of Public Contracts Scotland have any problems with the web site they should contact website Support Desk, contact details can be found by following the 'Contact Us' option on the left hand menu at http://www.publiccontractsscotland.gov.uk/default.aspx

### Lot Information

Lot 1

PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial, (Including Final Qualified Person Release, Storage and Distribution to Study Sites) and Option to Provide an Integrated IRT System with Forecasting Capabilities for the period of 18 months with the option to extend for a further period of up to 12 months. For detailed specification, please refer to PURCH3013 - Schedule 1A - Invitation to Tender

Renewal: Initial term is 18 months with optional extension of 12 months

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP564618 |
| Notice type | OJEU - F2 - Contract Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Selective |
| Procurement method details | Competitive procedure with negotiation |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Tender |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 16 Sep 2026 |
| Submission deadline | 19 Oct 2026 |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Active |
| Lots status | Active |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | University of Glasgow |
| Locality | GLASGOW |
| Postcode area | Glasgow |
| Postcode | G12 8QQ |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM3 West Central Scotland |
| ITL 3 | TLM32 Glasgow City |
| Local authority | Glasgow City |
| Electoral ward | Hillhead |
| Westminster constituency | Glasgow North |
| Delivery location | TLM82 Glasgow City |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33000000 - Medical equipments, pharmaceuticals and personal care products
- 33600000 - Pharmaceutical products

## Release History

- 16 Sep 2026 at 01:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP564618

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP564618
  PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial - PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial, (Including Final Qualified Person Release, Storage and Distribution to Study Sites) and Option to Provide an Integrated IRT System with Forecasting Capabilities. This procurement process is being conducted using the Competitive Procedure with Negotiation (CPN) in accordance with the requirements of Regulation 30 of the PC(S)R 2015. Although this procurement is being conducted under the Competitive Procedure with Negotiation (CPN), it is structured differently from a typical CPN process. This approach has been adopted to enhance the efficiency of evaluating supplier responses across both stages (SPD and ITT). Tender documents available from Public Contracts Scotland. Tender returns should be submitted via Public Contracts Scotland, no paper copies will be accepted. Should paper tenders be submitted, they will be rejected. Further to this any questions or communications regarding individual tender exercises must be sent via the Public Contracts Scotland Portal. Tender queries received through any other channel will not be answered. Should users of Public Contracts Scotland have any problems with the web site they should contact website Support Desk, contact details can be found by following the 'Contact Us' option on the left hand menu at http://www.publiccontractsscotland.gov.uk/default.aspx

## Notice URLs

- http://
- http://www.gla.ac.uk/
- http://www.publiccontractsscotland.gov.uk/
- http://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=843130
- http://www.publiccontractsscotland.gov.uk/default.aspx
- http://www.publiccontractsscotland.gov.uk/sitehelp/help_guides.aspx
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000843130
- https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000843130. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000843130.json.
